Catalytic activities of wild‐type <i>C. elegans</i><scp>DAF</scp>‐2 kinase and dauer‐associated mutants
Harini Krishnan(Stony Brook University), W. Todd Miller(Northport VA Medical Center)
Cited by 3
Related Papers
Podoplanin: An emerging cancer biomarker and therapeutic target
|Cancer Science|2018|194
Regulation of Ack-Family Nonreceptor Tyrosine Kinases
|Journal of Signal Transduction|2011|49
Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor
|The FASEB Journal|2024|0